2025 Annual Report
Annual Report
January 2026 news from the Sec Gen
News

January 2026 news from the Sec Gen

Dear colleagues and friends,As we begin a new year, I would like to thank you for your continued engagement and trust in ECETOC. 2026 promises to be an exciting and dynamic year, and I am pleased...
ECETOC launches Secondee Programme
News

ECETOC launches Secondee Programme

Looking for an extra challenge? A next step to help develop your career? Consider applying for our Secondee Programme!ECETOC is looking for early-career scientists currently working at a member co...
HSSD Tool

HSSD Tool

This software was developed by a consortium of partners to facilitate the uptake of novel approaches to estimate aquatic threshold concentrations (e.g. the concentration at which 5% of the species are exposed above their EC50, HC5).
The Human Exposure Assessment Tools Database (heatDB)

The Human Exposure Assessment Tools Database (heatDB)

heatdb is a public directory of exposure data sources as well as available tools for exposure
NanoApp

NanoApp

ECETOC’s NanoApp is a tool designed to define the boundaries of sets of similar nanoforms and to generate a justification for the REACH registration.
Targeted Risk Assessment (TRA)

Targeted Risk Assessment (TRA)

The Targeted Risk Assessment (TRA) estimates exposures to workers, consumers and the environment that arise during a series of events.
Chronic fish case studies towards an IATA

Chronic fish case studies towards an IATA

Why?Hazard and safety assessments for the pelagic compartment often rely on in vivo studies using a single fish species, raising ethical concerns and uncertainty in terms of extrapolation....
Estimating the environmental release of Synthetic Polymeric Microparticles from Products

Estimating the environmental release of Synthetic Polymeric Microparticles from Products

Why?REACH restriction: SPM use restricted; emissions reporting required by May 2027. Gap: No analytical methods available to measure SPM emissions. Solution: Draft SPERC-based approac...
Case Studies on Reliability and Relevance Considerations during Validation of NAMs

Case Studies on Reliability and Relevance Considerations during Validation of NAMs

Why?Validation of NAMs is often overlooked despite its importance for regulatory use. Traditional validation methods are less suitable for NAMs, which focus on key events rather than apical...
News
02.11.2009

Workshop looks at the enhancement of the scientific process and transparency of observational epidemiology studies

Environmental epidemiology studies are often treated with scepticism, even by the general public. In the past, scare stories based on findings from such studies, have turned out to be without foundation. There are many reasons for this, among them a pressure to have positive findings that can be published. This is compounded by the non-publication of negative findings and the difficulty to have such studies accepted for publication by high impact journals.

In view of these recurrent issues, ECETOC organised a workshop in London this 24-25 September at the Royal College of Physicians. Among the participants were leading experts from North America and Europe, from academia, government, science journals and industry.

The situation with such “observational studies' was compared with that which previously existed with clinical trials. In this case, it was shown that the trials showing a beneficial effect were more likely to be published than those which did not. One major step was the setting up of “clinical trials registries' which are open to the public and which provide a record of clinical trial designs and outcomes. These are supported by the editorial policies of key journals which only accept manuscripts if they were previously registered in these databases. In addition, the availability of the study protocol allows the results reported to be compared to the outcomes which were planned to be measured.

The workshop reached a consensus that it would be worthwhile to extend this approach to observational epidemiology studies. This approach was not considered to be a panacea, but would lead to improvements in the areas of ethics, transparency and universality (the availability of all data). As the existing databases hosted by the US NIH and the WHO were already suitable for this purpose, it was proposed that they be used, rather than starting a new system.